Healthcare professionals use the drug Gefitinib for treating metastatic non-small cell lung cancer (NSCLC) patients whose tumours have EGFR (epidermal growth factor receptor) exon 19 deletions or exon 21 substitution mutations. The medicine is a kinase inhibitor. It reversibly stops the kinase activity of wild-type and certain activating mutations of EGFR, preventing autophosphorylation of tyrosine residues related to the receptor, thereby inhibiting further downstream signalling and blocking EGFR-dependent proliferation. The tablets of Gefitinib come in 250 mg to administer orally via the mouth. The active ingredient in the tablet is Gefitinib, with inactive ingredients are lactose monohydrate, croscarmellose sodium, microcrystalline cellulose, povidone, sodium lauryl sulfate and magnesium stearate.
Gefitinib price in India is pocket-friendly, and one can buy this medicine from licensed suppliers of drugs. For further details, call us on 18008891064.
0
